Phibro Animal Health (PAHC) Raised to Hold at ValuEngine
A number of other analysts also recently weighed in on the company. Zacks Investment Research downgraded Phibro Animal Health from a “hold” rating to a “sell” rating in a research report on Tuesday, April 23rd. BidaskClub upgraded Phibro Animal Health from a “sell” rating to a “hold” rating in a research report on Friday, March 22nd. Gabelli upgraded Phibro Animal Health from a “hold” rating to a “buy” rating and set a $42.00 target price for the company in a research report on Wednesday, May 8th. They noted that the move was a valuation call. Finally, Guggenheim assumed coverage on Phibro Animal Health in a research report on Thursday. They issued a “neutral” rating for the company. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $43.50.
Shares of NASDAQ PAHC opened at $29.74 on Thursday. Phibro Animal Health has a 12 month low of $28.26 and a 12 month high of $54.62. The company has a quick ratio of 1.98, a current ratio of 3.41 and a debt-to-equity ratio of 1.48. The stock has a market cap of $1.20 billion, a PE ratio of 17.09, a price-to-earnings-growth ratio of 4.35 and a beta of 0.63.
Large investors have recently added to or reduced their stakes in the stock. Truvestments Capital LLC bought a new stake in Phibro Animal Health in the 1st quarter worth approximately $36,000. Quantamental Technologies LLC bought a new stake in Phibro Animal Health in the 4th quarter worth approximately $60,000. Advisory Services Network LLC lifted its position in Phibro Animal Health by 20.4% in the 4th quarter. Advisory Services Network LLC now owns 2,195 shares of the company’s stock worth $71,000 after buying an additional 372 shares during the last quarter. Advisors Asset Management Inc. lifted its position in Phibro Animal Health by 52.3% in the 4th quarter. Advisors Asset Management Inc. now owns 2,536 shares of the company’s stock worth $82,000 after buying an additional 871 shares during the last quarter. Finally, Advisor Group Inc. lifted its position in Phibro Animal Health by 40.2% in the 1st quarter. Advisor Group Inc. now owns 2,596 shares of the company’s stock worth $85,000 after buying an additional 745 shares during the last quarter. Institutional investors own 50.87% of the company’s stock.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.
Recommended Story: Google Finance Portfolio Tips and Tricks
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.